Search
for
Sort by
Research 31–60 of 1000+
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium
- Prenatal diagnosis of a foetus with partial monosomy 4p and partial trisomy 13q
- Therapeutic Approaches for Alopecia Areata in Children Aged 6 to 11 Years
- Long‐Term Real‐World Outcomes of Baricitinib in Severe Alopecia Areata: A 104‐Week Retrospective Analysis From a Single Institute
- 504 A single-center retrospective study evaluating the efficacy of intravenous methylprednisolone pulse therapy for 113 patients with alopecia areata
- Tofacitinib therapy for the treatment of alopecia areata: Report of 11 patients
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
- Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- UHPLC-Q-Orbitrap HRMS-based Metabolomics and In Silico Studies on 5-α-Reductase, JAK1, JAK2, and JAK3 of <i>Albizia saponaria</i> L.: Application to Alopecia
- Hair growth–promoting effects of Enz_MoriL on human dermal papilla cells through modulation of the Wnt/β-Catenin and JAK-STAT signaling pathways
- Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Autophagy Stimulation Improves Erythroid Proliferative Capacity in Models of SF3B1 Mutant MDS
- Les Rencontres d’Experts du Psoriasis : des recommandations pour la pratique quotidienne
- Response to “Reply to effectiveness of dutasteride in a large series of patients with FFA in real clinical practice”
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- The changing landscape of managing hair loss: a 30‐year perspective
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy